###begin article-title 0
###xml 27 33 27 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCDH15</italic>
A nonsynonymous SNP within PCDH15 is associated with lipid traits in familial combined hyperlipidemia
###end article-title 0
###begin p 1
###xml 292 298 292 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCDH15</italic>
###xml 453 459 453 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCDH15</italic>
###xml 678 679 678 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 824 825 824 825 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 871 872 871 872 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1016 1022 1016 1022 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCDH15</italic>
###xml 1068 1074 1068 1074 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCDH15</italic>
###xml 1243 1248 1243 1248 <sup xmlns:xlink="http://www.w3.org/1999/xlink">av-Tg</sup>
###xml 1259 1264 1259 1264 <sup xmlns:xlink="http://www.w3.org/1999/xlink">av-3J</sup>
###xml 1414 1419 1414 1419 <sup xmlns:xlink="http://www.w3.org/1999/xlink">av-3J</sup>
###xml 1463 1464 1463 1464 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1477 1478 1477 1478 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1527 1533 1527 1533 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCDH15</italic>
###xml 1036 1041 <span type="species:ncbi:9606">human</span>
###xml 1189 1193 <span type="species:ncbi:10090">mice</span>
Familial combined hyperlipidemia (FCHL) is a common lipid disorder characterized by the presence of multiple lipoprotein phenotypes that increase the risk of premature coronary heart disease. In a previous study, we identified an intragenic microsatellite marker within the protocadherin 15 (PCDH15) gene to be associated with high triglycerides (TGs) in Finnish dyslipidemic families. In this study we analyzed all four known nonsynonymous SNPs within PCDH15 in 1,268 individuals from Finnish and Dutch multigenerational families with FCHL. Association analyses of quantitative traits for SNPs were performed using the QTDT test. The nonsynonymous SNP rs10825269 resulted in a P = 0.0006 for the quantitative TG trait. Additional evidence for association was observed with the same SNP for apolipoprotein B levels (apo-B) (P = 0.0001) and total cholesterol (TC) levels (P = 0.001). None of the other three SNPs tested showed a significant association with any lipid-related trait. We investigated the expression of PCDH15 in different human tissues and observed that PCDH15 is expressed in several tissues including liver and pancreas. In addition, we measured the plasma lipid levels in mice with loss-of-function mutations in Pcdh15 (Pcdh15av-Tg and Pcdh15av-3J) to investigate possible abnormalities in their lipid profile. We observed a significant difference in plasma TG and TC concentrations for the Pcdh15av-3J carriers when compared with the wild type (P = 0.013 and P = 0.044, respectively). Our study suggests that PCDH15 is associated with lipid abnormalities.
###end p 1
###begin title 2
Introduction
###end title 2
###begin p 3
###xml 147 151 147 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">1973</xref>
###xml 278 282 278 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">1983</xref>
###xml 298 302 298 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR8">2003</xref>
###xml 408 412 408 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR25">1999</xref>
###xml 431 435 431 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR7">1999</xref>
###xml 452 456 452 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">2002</xref>
###xml 569 575 569 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCDH15</italic>
###xml 677 681 677 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR21">2004</xref>
###xml 697 703 697 703 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCDH15</italic>
###xml 825 829 825 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR25">1999</xref>
###xml 844 848 844 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR21">2004</xref>
###xml 873 877 873 877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">2005</xref>
###xml 880 886 880 886 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCDH15</italic>
###xml 1033 1039 1033 1039 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCDH15</italic>
###xml 1137 1141 1137 1141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2001</xref>
###xml 1160 1165 1160 1165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">2001a</xref>
###xml 1296 1300 1296 1300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR30">1964</xref>
###xml 1317 1321 1317 1321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR29">1965</xref>
###xml 1336 1340 1336 1340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">2006</xref>
###xml 1355 1359 1355 1359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">2007</xref>
###xml 1429 1435 1429 1435 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCDH15</italic>
###xml 1641 1647 1641 1647 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCDH15</italic>
###xml 1680 1685 <span type="species:ncbi:9606">human</span>
###xml 1745 1749 <span type="species:ncbi:10090">mice</span>
Familial combined hyperlipidemia (FCHL) is a complex disease characterized by hypertriglyceridemia, hypercholesterolemia or both (Goldstein et al. 1973). In addition, high serum levels of apolipoprotein-B (apo-B) are often observed in FCHL affected individuals (Brunzell et al. 1983; Ayyobi et al. 2003). Several genome-wide scans have been performed to detect susceptibility loci for FCHL (Pajukanta et al. 1999; Aouizerat et al. 1999; Allayee et al. 2002). In a previous study, we identified an intragenic microsatellite marker (D10S546) within the protocadherin 15 (PCDH15) to be associated with high serum triglycerides (TGs) in Finnish dyslipidemic families (Lilja et al. 2004). Furthermore, PCDH15 resides in a region on chromosome 10q11 that has been linked to lipid abnormalities in several studies (Pajukanta et al. 1999; Lilja et al. 2004; Huertas-Vazquez et al. 2005). PCDH15 is a member of the cadherin superfamily and encodes an integral membrane protein that mediates calcium-dependent cell-cell adhesion. Mutations in PCDH15 have been associated with hearing-loss and visual-loss due to retinitis pigmentosa (Ahmed et al. 2001; Alagramam et al. 2001a). Several previous epidemiological studies have demonstrated a relationship between hearing loss and hyperlipidemia (Rosen et al. 1964; Rosen and Olin 1965; Evans et al. 2006; Chang et al. 2007). In this study, we investigated all known nonsynonymous SNPs within PCDH15, rs11004439, rs10825269, rs4935502 rs2135720, for association with the FCHL component traits, TGs, total cholesterol (TC) and apo-B in multigenerational Finnish and Dutch families with FCHL as well as the PCDH15 expression pattern in different human tissues. In addition, we investigated the lipid profile in mice with two different loss-of-function mutations in Pcdh15.
###end p 3
###begin title 4
Subjects and methods
###end title 4
###begin title 5
Finnish FCHL families
###end title 5
###begin p 6
###xml 281 285 281 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR25">1999</xref>
###xml 299 303 299 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR32">2002</xref>
A total of 60 Finnish FCHL families comprising 719 individuals were included in this study. The families were recruited in the Helsinki and Turku University Central Hospitals. The inclusion and exclusion criteria for FCHL have been described in detail previously (Pajukanta et al. 1999; Soro et al. 2002). All subjects gave their informed consent. The study design was approved by the ethics committees of the participating centers.
###end p 6
###begin title 7
Dutch FCHL families
###end title 7
###begin p 8
###xml 303 307 303 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">2002</xref>
A total of 32 Dutch FCHL families comprising 549 individuals were included in this study. The families were recruited at the Lipid Clinic of the Utrecht Academic University Hospital, the Netherlands. The inclusion and exclusion criteria for FCHL have been described in detail previously (Allayee et al. 2002). All subjects provided written informed consent. The study design was approved by the ethics committee of the participating center.
###end p 8
###begin title 9
Biochemical analysis and SNP genotyping
###end title 9
###begin p 10
###xml 76 80 76 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR25">1999</xref>
###xml 94 98 94 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR32">2002</xref>
###xml 115 119 115 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">2002</xref>
###xml 168 174 168 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCDH15</italic>
Serum lipid parameters were measured as described earlier (Pajukanta et al. 1999; Soro et al. 2002; Allayee et al. 2002). We selected all nonsynonymous SNPs within the PCDH15 gene, rs11004439, rs10825269, rs4935502 and rs2135720, for genotyping. The SNP primers were designed for PCR using the Primer3 program, and for detection, using the SNP Primer Design software (Pyrosequencing). Genotyping of the 1,268 Finnish and Dutch FCHL family members was performed with the Pyrosequencing technique on the automated PSQ HS96A platform. All SNPs had at least 92% genotype call rate. For quality control, we replicated 3.5% of the genotyped samples. The percentage agreement between samples was >99%. All SNPs were tested for a possible violation of Hardy-Weinberg equilibrium (HWE).
###end p 10
###begin title 11
Statistical analysis
###end title 11
###begin p 12
###xml 154 158 154 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">2000</xref>
###xml 654 658 654 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR24">1998</xref>
###xml 661 662 661 662 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
All of the association analyses were performed using quantitative lipid traits. The quantitative transmission disequilibrium test (QTDT) (Abecasis et al. 2000) implemented in the genetic analysis package SOLAR. QTDT was performed for each analyzed trait in the Finnish and Dutch families, both separately and in the combined dataset. We analyzed the quantitative TG, TC, and apo-B, traits, as they are the key component traits of FCHL. The residuals for these traits were adjusted by age and sex in the total sample, using the SPSS 12.0 program. The PedCheck program was used to assess the genotype data for pedigree inconsistencies (O'Connell and Weeks 1998). P values of less than <0.05 after Bonferroni correction for multiple testing were considered statistically significant. However, it is worth noting that the Bonferroni correction for the probability values obtained in these analyses can be considered conservative, because we investigated highly correlated lipid traits. Apo-A1 and HDL-C traits were analyzed as secondary traits for rs10825269 after establishing the significant associations with TGs and apo-B.
###end p 12
###begin p 13
###xml 128 132 128 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR18">1976</xref>
###xml 134 138 134 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR19">2001</xref>
###xml 158 162 158 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR17">1983</xref>
###xml 585 586 585 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink">L</italic>
###xml 586 588 586 588 <sub xmlns:xlink="http://www.w3.org/1999/xlink">H1</sub>
###xml 595 596 595 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink">L</italic>
###xml 596 598 596 598 <sub xmlns:xlink="http://www.w3.org/1999/xlink">H2</sub>
###xml 608 609 608 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink">L</italic>
###xml 609 611 609 611 <sub xmlns:xlink="http://www.w3.org/1999/xlink">H1</sub>
###xml 661 662 661 662 <italic xmlns:xlink="http://www.w3.org/1999/xlink">L</italic>
###xml 662 664 662 664 <sub xmlns:xlink="http://www.w3.org/1999/xlink">H2</sub>
To analyze whether rs10825269 affects a combined trait of HDL-C and TGs, we utilized option 19 of Mendel software (Lange et al. 1976, 2001; Lange and Boehnke 1983). Mendel option 19 performs QTL association using a variance components model. We used a bivariate model consisting of an additive polygenic effect, a random environmental effect, and an additive SNP regression coefficient. Standardized residuals for HDL and Log(TG) were age and sex corrected, and proband ascertainment was corrected for within Mendel. A likelihood ratio test was performed using the formula: LRT = 2[ln(LH1) - ln(LH2)], where LH1 = maximum likelihood of the bivariate model, and LH2 = maximum likelihood of the bivariate model without the additive SNP regression coefficient.
###end p 13
###begin title 14
Simulation for functional change in coding nsSNPs
###end title 14
###begin p 15
###xml 130 147 130 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCDH15 in silico.</italic>
The PolyPhen software was used to investigate a possible impact of all nonsynonymous changes on the structure and function of the PCDH15 in silico.
###end p 15
###begin title 16
Cross species comparisons
###end title 16
###begin p 17
The cross species conservation of the nonsynonymous SNPs was evaluated using the UCSC genome browser.
###end p 17
###begin title 18
###xml 19 25 19 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCDH15</italic>
RT-PCR analysis of PCDH15 mRNA expression
###end title 18
###begin p 19
###xml 18 24 18 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCDH15</italic>
###xml 146 152 146 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCDH15</italic>
###xml 311 315 311 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR31">2006</xref>
###xml 534 535 530 531 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 53 58 <span type="species:ncbi:9606">human</span>
###xml 405 410 <span type="species:ncbi:9606">Human</span>
The expression of PCDH15 mRNA was analyzed using the human multiple tissue cDNA panel 1 (Clontech). Specific primers for the PCR amplification of PCDH15 were 5'CCAGGACAAGCTATG TACTTCGAGTCCAAG-3' (forward) and 5'-GACGAGTACATCGGCTTTGCCG CTCAGTC-3' (reverse), amplifying a 396 bp fragment (Rouget-Quermalet et al. 2006). Amplification of specific DNA fragments was performed by adding 3 mul of cDNA from the Human Tissue panel I to a PCR mixture containing 0.2 mM dNTPs, 0.4 muM of each primer, 2 mul of 10x reaction buffer, 1.5 muM MgCl2 and 0.2 mul of Taq DNA polymerase. PCR conditions were as follows: After initial denaturation for 10 min at 94degreesC, the reaction was subjected to 35 cycles of denaturation (30 s, 94degreesC), annealing (30 s, 61degreesC) and extension (1 min, 72degreesC). The amplified products were separated on a 1% agarose gel electrophoresis. G3PDH was used as a reference gene.
###end p 19
###begin title 20
Animals
###end title 20
###begin p 21
###xml 564 569 564 569 <sup xmlns:xlink="http://www.w3.org/1999/xlink">av-Tg</sup>
###xml 571 572 571 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 615 616 615 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 701 706 701 706 <sup xmlns:xlink="http://www.w3.org/1999/xlink">av-3J</sup>
###xml 708 709 708 709 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 747 748 747 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 854 859 854 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">2001b</xref>
###xml 8 12 <span type="species:ncbi:10090">mice</span>
###xml 180 184 <span type="species:ncbi:10090">mice</span>
###xml 231 236 <span type="species:ncbi:10090">mouse</span>
###xml 300 304 <span type="species:ncbi:10090">mice</span>
###xml 449 454 <span type="species:ncbi:10090">mouse</span>
###xml 498 502 <span type="species:ncbi:10090">mice</span>
###xml 792 796 <span type="species:ncbi:10090">mice</span>
All the mice serum samples were collected at the Department of Otolaryngology-Head and Neck Surgery, Case Western Reserve University, University Hospitals-Case Medical Center. All mice used in this study were maintained on regular mouse diet (6% fat IsoPro 3000 from Purina that contains 6% fat).The mice were fasted for 12 h, beginning one hour after the start of their light cycle. At the conclusion of the fast, the blood was collected from each mouse using a retro-orbital bleed. A total of 41 mice serums were collected for the FVB/N genetic background Pcdh15av-Tg (n = 13 mutants: 3 males and 10 females; and n = 8 controls: 4 males and 4 females), and for the C57BL/6J genetic background Pcdh15av-3J (n = 9 mutants: 5 males, 4 females; and n = 11 controls: 4 males, 7 females). Mutant mice were generated as described previously (Alagramam et al. 2001b). All animal experimental protocols were approved by Institutional Animal Care and Use Committee, Case Western Reserve University.
###end p 21
###begin title 22
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice serum lipid measurement
###end title 22
###begin p 23
###xml 157 161 157 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">2004</xref>
###xml 356 357 356 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 425 426 425 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 4 8 <span type="species:ncbi:10090">mice</span>
###xml 273 277 <span type="species:ncbi:10090">mice</span>
All mice were fed a normal diet for 100 days and lipid concentrations were determined. TC and TGs were determined as described previously (Castellani et al. 2004). Each lipid determination was measured in triplicate. The statistical analysis to evaluate differences in the mice lipid measurements was determined by using the unpaired, two tailed Student's t test. Sex was included as a covariate in these analyses. Values of P </= 0.05 were considered to be significant.
###end p 23
###begin title 24
Results
###end title 24
###begin p 25
###xml 106 107 106 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 139 145 139 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCDH15</italic>
###xml 372 373 372 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 537 538 537 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 556 557 556 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 575 576 575 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 650 651 650 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 797 798 797 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1103 1104 1103 1104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1142 1143 1142 1143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1251 1252 1251 1252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab2" ref-type="table">2</xref>
###xml 1480 1481 1480 1481 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1699 1706 1699 1706 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;1</label>
###xml 1706 1769 1706 1769 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="26">Mean lipid values of the 92 FCHL families included in the study</p>
###xml 1706 1769 1706 1769 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="26">Mean lipid values of the 92 FCHL families included in the study</p></caption>
###xml 1769 1769 1769 1769 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1769 1781 1769 1781 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Finnish FCHL</th>
###xml 1781 1791 1781 1791 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Dutch FCHL</th>
###xml 1769 1791 1769 1791 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left"/><th align="left">Finnish FCHL</th><th align="left">Dutch FCHL</th></tr>
###xml 1769 1791 1769 1791 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th align="left"/><th align="left">Finnish FCHL</th><th align="left">Dutch FCHL</th></tr></thead>
###xml 1791 1806 1791 1806 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">No. of families</td>
###xml 1806 1808 1806 1808 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">60</td>
###xml 1808 1810 1808 1810 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">32</td>
###xml 1791 1810 1791 1810 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">No. of families</td><td align="left">60</td><td align="left">32</td></tr>
###xml 1810 1831 1810 1831 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">No. of subjects (M/F)</td>
###xml 1831 1844 1831 1844 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">719 (356/363)</td>
###xml 1844 1857 1844 1857 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">549 (273/276)</td>
###xml 1810 1857 1810 1857 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">No. of subjects (M/F)</td><td align="left">719 (356/363)</td><td align="left">549 (273/276)</td></tr>
###xml 1857 1880 1857 1878 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">TG, mg/dl (mean&#160;&#177;&#160;SD)</td>
###xml 1880 1895 1878 1891 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">316.4&#160;&#177;&#160;151.0</td>
###xml 1895 1910 1891 1904 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">315.0&#160;&#177;&#160;201.7</td>
###xml 1857 1910 1857 1904 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">TG, mg/dl (mean&#160;&#177;&#160;SD)</td><td align="left">316.4&#160;&#177;&#160;151.0</td><td align="left">315.0&#160;&#177;&#160;201.7</td></tr>
###xml 1910 1933 1904 1925 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">TC, mg/dl (mean&#160;&#177;&#160;SD)</td>
###xml 1933 1947 1925 1937 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">298.8&#160;&#177;&#160;41.3</td>
###xml 1947 1961 1937 1949 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">301.7&#160;&#177;&#160;61.2</td>
###xml 1910 1961 1904 1949 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">TC, mg/dl (mean&#160;&#177;&#160;SD)</td><td align="left">298.8&#160;&#177;&#160;41.3</td><td align="left">301.7&#160;&#177;&#160;61.2</td></tr>
###xml 1961 1987 1949 1973 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Apo-B, mg/dl (mean&#160;&#177;&#160;SD)</td>
###xml 1987 2001 1973 1985 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">146.7&#160;&#177;&#160;31.1</td>
###xml 2001 2015 1985 1997 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">141.8&#160;&#177;&#160;24.6</td>
###xml 1961 2015 1949 1997 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Apo-B, mg/dl (mean&#160;&#177;&#160;SD)</td><td align="left">146.7&#160;&#177;&#160;31.1</td><td align="left">141.8&#160;&#177;&#160;24.6</td></tr>
###xml 2015 2041 1997 2021 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">HDL-C, mg/dl (mean&#160;&#177;&#160;SD)</td>
###xml 2041 2054 2021 2032 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">40.9&#160;&#177;&#160;13.1</td>
###xml 2054 2067 2032 2043 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">39.4&#160;&#177;&#160;12.8</td>
###xml 2015 2067 1997 2043 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">HDL-C, mg/dl (mean&#160;&#177;&#160;SD)</td><td align="left">40.9&#160;&#177;&#160;13.1</td><td align="left">39.4&#160;&#177;&#160;12.8</td></tr>
###xml 1791 2067 1791 2043 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td align="left">No. of families</td><td align="left">60</td><td align="left">32</td></tr><tr><td align="left">No. of subjects (M/F)</td><td align="left">719 (356/363)</td><td align="left">549 (273/276)</td></tr><tr><td align="left">TG, mg/dl (mean&#160;&#177;&#160;SD)</td><td align="left">316.4&#160;&#177;&#160;151.0</td><td align="left">315.0&#160;&#177;&#160;201.7</td></tr><tr><td align="left">TC, mg/dl (mean&#160;&#177;&#160;SD)</td><td align="left">298.8&#160;&#177;&#160;41.3</td><td align="left">301.7&#160;&#177;&#160;61.2</td></tr><tr><td align="left">Apo-B, mg/dl (mean&#160;&#177;&#160;SD)</td><td align="left">146.7&#160;&#177;&#160;31.1</td><td align="left">141.8&#160;&#177;&#160;24.6</td></tr><tr><td align="left">HDL-C, mg/dl (mean&#160;&#177;&#160;SD)</td><td align="left">40.9&#160;&#177;&#160;13.1</td><td align="left">39.4&#160;&#177;&#160;12.8</td></tr></tbody>
###xml 1769 2067 1769 2043 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Finnish FCHL</th><th align="left">Dutch FCHL</th></tr></thead><tbody><tr><td align="left">No. of families</td><td align="left">60</td><td align="left">32</td></tr><tr><td align="left">No. of subjects (M/F)</td><td align="left">719 (356/363)</td><td align="left">549 (273/276)</td></tr><tr><td align="left">TG, mg/dl (mean&#160;&#177;&#160;SD)</td><td align="left">316.4&#160;&#177;&#160;151.0</td><td align="left">315.0&#160;&#177;&#160;201.7</td></tr><tr><td align="left">TC, mg/dl (mean&#160;&#177;&#160;SD)</td><td align="left">298.8&#160;&#177;&#160;41.3</td><td align="left">301.7&#160;&#177;&#160;61.2</td></tr><tr><td align="left">Apo-B, mg/dl (mean&#160;&#177;&#160;SD)</td><td align="left">146.7&#160;&#177;&#160;31.1</td><td align="left">141.8&#160;&#177;&#160;24.6</td></tr><tr><td align="left">HDL-C, mg/dl (mean&#160;&#177;&#160;SD)</td><td align="left">40.9&#160;&#177;&#160;13.1</td><td align="left">39.4&#160;&#177;&#160;12.8</td></tr></tbody></table>
###xml 2067 2070 2043 2046 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M/F</italic>
###xml 2084 2086 2060 2062 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TG</italic>
###xml 2102 2104 2078 2080 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TC</italic>
###xml 2124 2129 2100 2105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apo-B</italic>
###xml 2148 2153 2124 2129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HDL-C</italic>
###xml 2067 2169 2043 2145 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="27"><italic>M/F</italic> male/female, <italic>TG</italic> triglycerides, <italic>TC</italic> total cholesterol, <italic>Apo-B</italic> apolipoprotein-B, <italic>HDL-C</italic> HDL cholesterol</p>
###xml 2067 2169 2043 2145 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="27"><italic>M/F</italic> male/female, <italic>TG</italic> triglycerides, <italic>TC</italic> total cholesterol, <italic>Apo-B</italic> apolipoprotein-B, <italic>HDL-C</italic> HDL cholesterol</p></table-wrap-foot>
###xml 1699 2169 1699 2145 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab1"><label>Table&#160;1</label><caption><p textid="26">Mean lipid values of the 92 FCHL families included in the study</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Finnish FCHL</th><th align="left">Dutch FCHL</th></tr></thead><tbody><tr><td align="left">No. of families</td><td align="left">60</td><td align="left">32</td></tr><tr><td align="left">No. of subjects (M/F)</td><td align="left">719 (356/363)</td><td align="left">549 (273/276)</td></tr><tr><td align="left">TG, mg/dl (mean&#160;&#177;&#160;SD)</td><td align="left">316.4&#160;&#177;&#160;151.0</td><td align="left">315.0&#160;&#177;&#160;201.7</td></tr><tr><td align="left">TC, mg/dl (mean&#160;&#177;&#160;SD)</td><td align="left">298.8&#160;&#177;&#160;41.3</td><td align="left">301.7&#160;&#177;&#160;61.2</td></tr><tr><td align="left">Apo-B, mg/dl (mean&#160;&#177;&#160;SD)</td><td align="left">146.7&#160;&#177;&#160;31.1</td><td align="left">141.8&#160;&#177;&#160;24.6</td></tr><tr><td align="left">HDL-C, mg/dl (mean&#160;&#177;&#160;SD)</td><td align="left">40.9&#160;&#177;&#160;13.1</td><td align="left">39.4&#160;&#177;&#160;12.8</td></tr></tbody></table><table-wrap-foot><p textid="27"><italic>M/F</italic> male/female, <italic>TG</italic> triglycerides, <italic>TC</italic> total cholesterol, <italic>Apo-B</italic> apolipoprotein-B, <italic>HDL-C</italic> HDL cholesterol</p></table-wrap-foot></table-wrap>
###xml 2169 2176 2145 2152 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;2</label>
###xml 2176 2324 2152 2300 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="28">Quantitative family-based association analysis of lipid phenotypes with SNP rs10825269 in the Finnish and Dutch FCHL families using the QTDT program</p>
###xml 2176 2324 2152 2300 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="28">Quantitative family-based association analysis of lipid phenotypes with SNP rs10825269 in the Finnish and Dutch FCHL families using the QTDT program</p></caption>
###xml 2324 2329 2300 2305 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Trait</th>
###xml 2329 2347 2305 2323 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Major/minor allele</th>
###xml 2347 2369 2323 2345 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Minor allele frequency</th>
###xml 2373 2374 2349 2350 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 2369 2374 2345 2350 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">QTDT<sup>a</sup></th>
###xml 2378 2379 2354 2355 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 2374 2379 2350 2355 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">QTDT<sup>b</sup></th>
###xml 2324 2379 2300 2355 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left">Trait</th><th align="left">Major/minor allele</th><th align="left">Minor allele frequency</th><th align="left">QTDT<sup>a</sup></th><th align="left">QTDT<sup>b</sup></th></tr>
###xml 2324 2379 2300 2355 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th align="left">Trait</th><th align="left">Major/minor allele</th><th align="left">Minor allele frequency</th><th align="left">QTDT<sup>a</sup></th><th align="left">QTDT<sup>b</sup></th></tr></thead>
###xml 2379 2381 2355 2357 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">TG</td>
###xml 2381 2382 2357 2358 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 2381 2384 2357 2360 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><bold>C</bold>/T</td>
###xml 2384 2388 2360 2364 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.10</td>
###xml 2388 2394 2364 2370 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.0006</td>
###xml 2394 2398 2370 2374 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.01</td>
###xml 2379 2398 2355 2374 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">TG</td><td align="left"><bold>C</bold>/T</td><td char="." align="char">0.10</td><td char="." align="char">0.0006</td><td char="." align="char">0.01</td></tr>
###xml 2398 2403 2374 2379 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Apo-B</td>
###xml 2403 2404 2379 2380 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 2403 2406 2379 2382 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><bold>C</bold>/T</td>
###xml 2406 2410 2382 2386 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.10</td>
###xml 2410 2416 2386 2392 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.0001</td>
###xml 2416 2421 2392 2397 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.002</td>
###xml 2398 2421 2374 2397 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Apo-B</td><td align="left"><bold>C</bold>/T</td><td char="." align="char">0.10</td><td char="." align="char">0.0001</td><td char="." align="char">0.002</td></tr>
###xml 2421 2423 2397 2399 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">TC</td>
###xml 2423 2424 2399 2400 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 2423 2426 2399 2402 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><bold>C</bold>/T</td>
###xml 2426 2430 2402 2406 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.10</td>
###xml 2430 2435 2406 2411 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.001</td>
###xml 2435 2439 2411 2415 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.02</td>
###xml 2421 2439 2397 2415 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">TC</td><td align="left"><bold>C</bold>/T</td><td char="." align="char">0.10</td><td char="." align="char">0.001</td><td char="." align="char">0.02</td></tr>
###xml 2379 2439 2355 2415 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td align="left">TG</td><td align="left"><bold>C</bold>/T</td><td char="." align="char">0.10</td><td char="." align="char">0.0006</td><td char="." align="char">0.01</td></tr><tr><td align="left">Apo-B</td><td align="left"><bold>C</bold>/T</td><td char="." align="char">0.10</td><td char="." align="char">0.0001</td><td char="." align="char">0.002</td></tr><tr><td align="left">TC</td><td align="left"><bold>C</bold>/T</td><td char="." align="char">0.10</td><td char="." align="char">0.001</td><td char="." align="char">0.02</td></tr></tbody>
###xml 2324 2439 2300 2415 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th align="left">Trait</th><th align="left">Major/minor allele</th><th align="left">Minor allele frequency</th><th align="left">QTDT<sup>a</sup></th><th align="left">QTDT<sup>b</sup></th></tr></thead><tbody><tr><td align="left">TG</td><td align="left"><bold>C</bold>/T</td><td char="." align="char">0.10</td><td char="." align="char">0.0006</td><td char="." align="char">0.01</td></tr><tr><td align="left">Apo-B</td><td align="left"><bold>C</bold>/T</td><td char="." align="char">0.10</td><td char="." align="char">0.0001</td><td char="." align="char">0.002</td></tr><tr><td align="left">TC</td><td align="left"><bold>C</bold>/T</td><td char="." align="char">0.10</td><td char="." align="char">0.001</td><td char="." align="char">0.02</td></tr></tbody></table>
###xml 2439 2475 2415 2451 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="29">The risk allele is indicated in bold</p>
###xml 2475 2477 2451 2453 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TG</italic>
###xml 2493 2495 2469 2471 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TC</italic>
###xml 2515 2520 2491 2496 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apo-B</italic>
###xml 2475 2537 2451 2513 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="30"><italic>TG</italic> triglycerides, <italic>TC</italic> total cholesterol, <italic>apo-B</italic> apolipoprotein-B</p>
###xml 2537 2538 2513 2514 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 2550 2551 2526 2527 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 2537 2726 2513 2702 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="31"><sup>a</sup>Uncorrected <italic>P</italic> values (The Bonferroni correction for the probability values obtained in these analyses can be considered conservative, because we investigate highly correlated lipid traits)</p>
###xml 2726 2727 2702 2703 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 2727 2728 2703 2704 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 2726 2828 2702 2804 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="32"><sup>b</sup><italic>P</italic> values obtained after Bonferroni correction for 24 test (4 SNPs, 3 traits, 2 different populations)</p>
###xml 2439 2828 2415 2804 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="29">The risk allele is indicated in bold</p><p textid="30"><italic>TG</italic> triglycerides, <italic>TC</italic> total cholesterol, <italic>apo-B</italic> apolipoprotein-B</p><p textid="31"><sup>a</sup>Uncorrected <italic>P</italic> values (The Bonferroni correction for the probability values obtained in these analyses can be considered conservative, because we investigate highly correlated lipid traits)</p><p textid="32"><sup>b</sup><italic>P</italic> values obtained after Bonferroni correction for 24 test (4 SNPs, 3 traits, 2 different populations)</p></table-wrap-foot>
###xml 2169 2828 2145 2804 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab2"><label>Table&#160;2</label><caption><p textid="28">Quantitative family-based association analysis of lipid phenotypes with SNP rs10825269 in the Finnish and Dutch FCHL families using the QTDT program</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Trait</th><th align="left">Major/minor allele</th><th align="left">Minor allele frequency</th><th align="left">QTDT<sup>a</sup></th><th align="left">QTDT<sup>b</sup></th></tr></thead><tbody><tr><td align="left">TG</td><td align="left"><bold>C</bold>/T</td><td char="." align="char">0.10</td><td char="." align="char">0.0006</td><td char="." align="char">0.01</td></tr><tr><td align="left">Apo-B</td><td align="left"><bold>C</bold>/T</td><td char="." align="char">0.10</td><td char="." align="char">0.0001</td><td char="." align="char">0.002</td></tr><tr><td align="left">TC</td><td align="left"><bold>C</bold>/T</td><td char="." align="char">0.10</td><td char="." align="char">0.001</td><td char="." align="char">0.02</td></tr></tbody></table><table-wrap-foot><p textid="29">The risk allele is indicated in bold</p><p textid="30"><italic>TG</italic> triglycerides, <italic>TC</italic> total cholesterol, <italic>apo-B</italic> apolipoprotein-B</p><p textid="31"><sup>a</sup>Uncorrected <italic>P</italic> values (The Bonferroni correction for the probability values obtained in these analyses can be considered conservative, because we investigate highly correlated lipid traits)</p><p textid="32"><sup>b</sup><italic>P</italic> values obtained after Bonferroni correction for 24 test (4 SNPs, 3 traits, 2 different populations)</p></table-wrap-foot></table-wrap>
The mean lipid values of the 92 Dutch and Finnish FCHL families included in this study are shown in Table 1. All nonsynonymous SNPs within PCDH15 were genotyped in these 92 Finnish and Dutch FCHL families. Genotype distributions for the four investigated SNPs in both populations were consistent with the Hardy-Weinberg equilibrium in nonrelated groups of family members (P > 0.05). Of the four nonsynonymous SNPs investigated, SNP rs10825269 showed significant evidence for association for the different quantitative lipid traits, TGs (P = 0.001), apo-B (P = 0.002) and TC (P = 0.04) in the Finns, and for the quantitative apo-B trait in the Dutch (P = 0.04) for the same allele (C). No significant association signals were observed with the other three SNPs rs11004439, rs4935502 and rs2135720 (P > 0.05). None of the investigated SNPs were in linkage disequilibrium with each other. Next we performed a combined data analysis of both the Finnish and Dutch families with FCHL, and observed a significant increase of statistical significance for all investigated quantitative lipid traits (uncorrected P = 0.001-0.0001, Bonferroni corrected P = 0.02-0.002). Association results for the combined study sample for SNP rs10825269 are presented in Table 2. We also investigated the nonsynonymous SNP rs10825269 within PCDH15 for associations with quantitative Apo-A1 and HDL-C levels in the Finnish and Dutch FCHL families. No evidence for association was observed for these traits (P > 0.05). The frequency of the minor allele of the SNP rs10825269 in both populations was 10%, which is in a good agreement with the allele frequency reported by the International HapMap project in the CEPH samples ().Table 1Mean lipid values of the 92 FCHL families included in the studyFinnish FCHLDutch FCHLNo. of families6032No. of subjects (M/F)719 (356/363)549 (273/276)TG, mg/dl (mean +/- SD)316.4 +/- 151.0315.0 +/- 201.7TC, mg/dl (mean +/- SD)298.8 +/- 41.3301.7 +/- 61.2Apo-B, mg/dl (mean +/- SD)146.7 +/- 31.1141.8 +/- 24.6HDL-C, mg/dl (mean +/- SD)40.9 +/- 13.139.4 +/- 12.8M/F male/female, TG triglycerides, TC total cholesterol, Apo-B apolipoprotein-B, HDL-C HDL cholesterolTable 2Quantitative family-based association analysis of lipid phenotypes with SNP rs10825269 in the Finnish and Dutch FCHL families using the QTDT programTraitMajor/minor alleleMinor allele frequencyQTDTaQTDTbTGC/T0.100.00060.01Apo-BC/T0.100.00010.002TCC/T0.100.0010.02The risk allele is indicated in boldTG triglycerides, TC total cholesterol, apo-B apolipoprotein-BaUncorrected P values (The Bonferroni correction for the probability values obtained in these analyses can be considered conservative, because we investigate highly correlated lipid traits)bP values obtained after Bonferroni correction for 24 test (4 SNPs, 3 traits, 2 different populations)
###end p 25
###begin p 26
Mean lipid values of the 92 FCHL families included in the study
###end p 26
###begin p 27
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M/F</italic>
###xml 17 19 17 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TG</italic>
###xml 35 37 35 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TC</italic>
###xml 57 62 57 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apo-B</italic>
###xml 81 86 81 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HDL-C</italic>
M/F male/female, TG triglycerides, TC total cholesterol, Apo-B apolipoprotein-B, HDL-C HDL cholesterol
###end p 27
###begin p 28
Quantitative family-based association analysis of lipid phenotypes with SNP rs10825269 in the Finnish and Dutch FCHL families using the QTDT program
###end p 28
###begin p 29
The risk allele is indicated in bold
###end p 29
###begin p 30
###xml 0 2 0 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TG</italic>
###xml 18 20 18 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TC</italic>
###xml 40 45 40 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apo-B</italic>
TG triglycerides, TC total cholesterol, apo-B apolipoprotein-B
###end p 30
###begin p 31
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 13 14 13 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
aUncorrected P values (The Bonferroni correction for the probability values obtained in these analyses can be considered conservative, because we investigate highly correlated lipid traits)
###end p 31
###begin p 32
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
bP values obtained after Bonferroni correction for 24 test (4 SNPs, 3 traits, 2 different populations)
###end p 32
###begin p 33
###xml 152 156 152 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR21">2004</xref>
###xml 368 372 368 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR18">1976</xref>
###xml 374 378 374 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR19">2001</xref>
###xml 398 402 398 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR17">1983</xref>
###xml 409 429 409 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Sec2" ref-type="sec">Subjects and methods</xref>
###xml 518 519 518 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
The chromosomal region on 10q11, where PCDH15 is located, was also implicated for a combined trait of HDL-C and TGs in our previous study (Lilja et al. 2004). Therefore, we investigated whether rs10825269 affects the combined trait of HDL-C and TGs in the Dutch and Finnish families with FCHL. For this analysis, we utilized option 19 of Mendel software (Lange et al. 1976, 2001; Lange and Boehnke 1983) (see Subjects and methods section). We observed that rs10825269 does not significantly alter this combined trait (P = 0.08).
###end p 33
###begin p 34
###xml 385 391 385 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCDH15</italic>
###xml 471 472 471 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 473 479 473 479 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;1</label>
###xml 514 520 514 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCDH15</italic>
###xml 522 523 522 523 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 567 573 567 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCDH15</italic>
###xml 575 580 575 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N-ter</italic>
###xml 620 622 620 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C1</italic>
###xml 642 644 642 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C2</italic>
###xml 670 675 670 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C-ter</italic>
###xml 715 716 715 716 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 783 789 783 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCDH15</italic>
###xml 821 823 821 823 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hs</italic>
###xml 838 840 838 840 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pt</italic>
###xml 858 860 858 860 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rm</italic>
###xml 870 872 870 872 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mm</italic>
###xml 880 882 880 882 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rt</italic>
###xml 890 892 890 892 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cf</italic>
###xml 906 908 906 908 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dn</italic>
###xml 921 923 921 923 <italic xmlns:xlink="http://www.w3.org/1999/xlink">la</italic>
###xml 933 935 933 935 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ec</italic>
###xml 938 939 938 939 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 948 949 948 949 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 959 960 959 960 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 970 971 970 971 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 987 988 987 988 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 998 1000 998 1000 <italic xmlns:xlink="http://www.w3.org/1999/xlink"> Q</italic>
###xml 1012 1013 1012 1013 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 479 1074 479 1074 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="35">Nonsynonymous sequence variants in <italic>PCDH15</italic>. <bold>a</bold> All nonsynonymous sequence variants within <italic>PCDH15</italic>. <italic>N-ter</italic> N-terminus of the amino acid sequence, <italic>C1</italic> cadherin domain 1, <italic>C2</italic> cadherin domain 2, etc.; <italic>C-ter</italic> C-terminus of the amino acid sequence. <bold>b</bold> Sequence conservation across species of nonsynonymous variants in <italic>PCDH15</italic>. The alignment includes Human (<italic>hs</italic>), chimpanzee (<italic>pt</italic>), rhesus monkey (<italic>rm</italic>), mouse (<italic>mm</italic>), rat (<italic>rt</italic>), dog (<italic>cf</italic>), armadillo (<italic>dn</italic>), elephant (<italic>la</italic>), horse (<italic>ec</italic>). <italic>S</italic> serine, <italic>A</italic> alanine, <italic>G</italic> glycine, <italic>D</italic> aspartic acid, <italic>R</italic> Arginine,<italic> Q</italic> Glutamine, <italic>N</italic> aligning has one or more unalignable bases in the gap region</p>
###xml 479 1074 479 1074 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="35">Nonsynonymous sequence variants in <italic>PCDH15</italic>. <bold>a</bold> All nonsynonymous sequence variants within <italic>PCDH15</italic>. <italic>N-ter</italic> N-terminus of the amino acid sequence, <italic>C1</italic> cadherin domain 1, <italic>C2</italic> cadherin domain 2, etc.; <italic>C-ter</italic> C-terminus of the amino acid sequence. <bold>b</bold> Sequence conservation across species of nonsynonymous variants in <italic>PCDH15</italic>. The alignment includes Human (<italic>hs</italic>), chimpanzee (<italic>pt</italic>), rhesus monkey (<italic>rm</italic>), mouse (<italic>mm</italic>), rat (<italic>rt</italic>), dog (<italic>cf</italic>), armadillo (<italic>dn</italic>), elephant (<italic>la</italic>), horse (<italic>ec</italic>). <italic>S</italic> serine, <italic>A</italic> alanine, <italic>G</italic> glycine, <italic>D</italic> aspartic acid, <italic>R</italic> Arginine,<italic> Q</italic> Glutamine, <italic>N</italic> aligning has one or more unalignable bases in the gap region</p></caption>
###xml 1074 1074 1074 1074 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="439_2009_749_Fig1_HTML" id="MO1"/>
###xml 473 1074 473 1074 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig1"><label>Fig.&#160;1</label><caption><p textid="35">Nonsynonymous sequence variants in <italic>PCDH15</italic>. <bold>a</bold> All nonsynonymous sequence variants within <italic>PCDH15</italic>. <italic>N-ter</italic> N-terminus of the amino acid sequence, <italic>C1</italic> cadherin domain 1, <italic>C2</italic> cadherin domain 2, etc.; <italic>C-ter</italic> C-terminus of the amino acid sequence. <bold>b</bold> Sequence conservation across species of nonsynonymous variants in <italic>PCDH15</italic>. The alignment includes Human (<italic>hs</italic>), chimpanzee (<italic>pt</italic>), rhesus monkey (<italic>rm</italic>), mouse (<italic>mm</italic>), rat (<italic>rt</italic>), dog (<italic>cf</italic>), armadillo (<italic>dn</italic>), elephant (<italic>la</italic>), horse (<italic>ec</italic>). <italic>S</italic> serine, <italic>A</italic> alanine, <italic>G</italic> glycine, <italic>D</italic> aspartic acid, <italic>R</italic> Arginine,<italic> Q</italic> Glutamine, <italic>N</italic> aligning has one or more unalignable bases in the gap region</p></caption><graphic position="anchor" xlink:href="439_2009_749_Fig1_HTML" id="MO1"/></fig>
###xml 814 819 <span type="species:ncbi:9606">Human</span>
###xml 826 836 <span type="species:ncbi:9598">chimpanzee</span>
###xml 843 856 <span type="species:ncbi:9544">rhesus monkey</span>
###xml 863 868 <span type="species:ncbi:10090">mouse</span>
###xml 875 878 <span type="species:ncbi:10116">rat</span>
###xml 885 888 <span type="species:ncbi:9615">dog</span>
###xml 911 919 <span type="species:ncbi:99490|species:ncbi:9783|species:ncbi:9785">elephant</span>
###xml 926 931 <span type="species:ncbi:9796">horse</span>
The nonsynonymous changes of rs10825269, rs11004439 and rs2135720 were predicted to be benign by the PolyPhen software (PSIC score difference: 0.057, 1.023 and 1.034, respectively). The SNP rs4935720, 166 bp away from SNP rs10825269, was predicted to be possibly damaging (PSIC score 1.7). We also examined the sequence conservation across species of the nonsynonymous variants within PCDH15. The cross-species conservations of these nonsynonymous SNPs are shown in Fig. 1.Fig. 1Nonsynonymous sequence variants in PCDH15. a All nonsynonymous sequence variants within PCDH15. N-ter N-terminus of the amino acid sequence, C1 cadherin domain 1, C2 cadherin domain 2, etc.; C-ter C-terminus of the amino acid sequence. b Sequence conservation across species of nonsynonymous variants in PCDH15. The alignment includes Human (hs), chimpanzee (pt), rhesus monkey (rm), mouse (mm), rat (rt), dog (cf), armadillo (dn), elephant (la), horse (ec). S serine, A alanine, G glycine, D aspartic acid, R Arginine, Q Glutamine, N aligning has one or more unalignable bases in the gap region
###end p 34
###begin p 35
###xml 35 41 35 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCDH15</italic>
###xml 43 44 43 44 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 88 94 88 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCDH15</italic>
###xml 96 101 96 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N-ter</italic>
###xml 141 143 141 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C1</italic>
###xml 163 165 163 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C2</italic>
###xml 191 196 191 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C-ter</italic>
###xml 236 237 236 237 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 304 310 304 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCDH15</italic>
###xml 342 344 342 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hs</italic>
###xml 359 361 359 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pt</italic>
###xml 379 381 379 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rm</italic>
###xml 391 393 391 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mm</italic>
###xml 401 403 401 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rt</italic>
###xml 411 413 411 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cf</italic>
###xml 427 429 427 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dn</italic>
###xml 442 444 442 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">la</italic>
###xml 454 456 454 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ec</italic>
###xml 459 460 459 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 469 470 469 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 480 481 480 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 491 492 491 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 508 509 508 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 519 521 519 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink"> Q</italic>
###xml 533 534 533 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 335 340 <span type="species:ncbi:9606">Human</span>
###xml 347 357 <span type="species:ncbi:9598">chimpanzee</span>
###xml 364 377 <span type="species:ncbi:9544">rhesus monkey</span>
###xml 384 389 <span type="species:ncbi:10090">mouse</span>
###xml 396 399 <span type="species:ncbi:10116">rat</span>
###xml 406 409 <span type="species:ncbi:9615">dog</span>
###xml 432 440 <span type="species:ncbi:99490|species:ncbi:9783|species:ncbi:9785">elephant</span>
###xml 447 452 <span type="species:ncbi:9796">horse</span>
Nonsynonymous sequence variants in PCDH15. a All nonsynonymous sequence variants within PCDH15. N-ter N-terminus of the amino acid sequence, C1 cadherin domain 1, C2 cadherin domain 2, etc.; C-ter C-terminus of the amino acid sequence. b Sequence conservation across species of nonsynonymous variants in PCDH15. The alignment includes Human (hs), chimpanzee (pt), rhesus monkey (rm), mouse (mm), rat (rt), dog (cf), armadillo (dn), elephant (la), horse (ec). S serine, A alanine, G glycine, D aspartic acid, R Arginine, Q Glutamine, N aligning has one or more unalignable bases in the gap region
###end p 35
###begin p 36
###xml 49 55 49 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCDH15</italic>
###xml 180 186 180 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCDH15</italic>
###xml 259 260 259 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 294 300 294 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCDH15</italic>
###xml 330 336 330 336 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;2</label>
###xml 359 365 359 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCDH15</italic>
###xml 396 407 396 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink">upper panel</italic>
###xml 448 459 448 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lower panel</italic>
###xml 336 460 336 460 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="37">Expression patterns of <italic>PCDH15</italic> in eight human adult tissues (<italic>upper panel</italic>). G3PDH was used as a positive control (<italic>lower panel</italic>)</p>
###xml 336 460 336 460 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="37">Expression patterns of <italic>PCDH15</italic> in eight human adult tissues (<italic>upper panel</italic>). G3PDH was used as a positive control (<italic>lower panel</italic>)</p></caption>
###xml 460 460 460 460 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="439_2009_749_Fig2_HTML" id="MO2"/>
###xml 330 460 330 460 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig2"><label>Fig.&#160;2</label><caption><p textid="37">Expression patterns of <italic>PCDH15</italic> in eight human adult tissues (<italic>upper panel</italic>). G3PDH was used as a positive control (<italic>lower panel</italic>)</p></caption><graphic position="anchor" xlink:href="439_2009_749_Fig2_HTML" id="MO2"/></fig>
###xml 69 74 <span type="species:ncbi:9606">human</span>
###xml 102 107 <span type="species:ncbi:9606">human</span>
###xml 310 315 <span type="species:ncbi:9606">human</span>
###xml 375 380 <span type="species:ncbi:9606">human</span>
Next, we investigated the tissue distribution of PCDH15 in different human tissues using a commercial human multiple tissue cDNA panel of eight different tissues. We observed that PCDH15 was expressed in brain, heart, kidney, liver, lung and pancreas. Figure 2 shows the expression patterns of PCDH15 in eight human adult tissues.Fig. 2Expression patterns of PCDH15 in eight human adult tissues (upper panel). G3PDH was used as a positive control (lower panel)
###end p 36
###begin p 37
###xml 23 29 23 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCDH15</italic>
###xml 60 71 60 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">upper panel</italic>
###xml 112 123 112 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lower panel</italic>
###xml 39 44 <span type="species:ncbi:9606">human</span>
Expression patterns of PCDH15 in eight human adult tissues (upper panel). G3PDH was used as a positive control (lower panel)
###end p 37
###begin p 38
###xml 205 210 205 210 <sup xmlns:xlink="http://www.w3.org/1999/xlink">av-Tg</sup>
###xml 221 226 221 226 <sup xmlns:xlink="http://www.w3.org/1999/xlink">av-3J</sup>
###xml 234 235 234 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3</xref>
###xml 327 332 327 332 <sup xmlns:xlink="http://www.w3.org/1999/xlink">av-3J</sup>
###xml 379 380 379 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 393 394 393 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 424 425 424 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3</xref>
###xml 502 507 502 507 <sup xmlns:xlink="http://www.w3.org/1999/xlink">av-Tg</sup>
###xml 570 576 570 576 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;3</label>
###xml 576 577 576 577 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 653 668 653 668 <italic xmlns:xlink="http://www.w3.org/1999/xlink">solid rectangle</italic>
###xml 751 756 751 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N-ter</italic>
###xml 796 798 796 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C1</italic>
###xml 818 820 818 820 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C2</italic>
###xml 846 851 846 851 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C-ter</italic>
###xml 891 892 891 892 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 993 998 993 998 <sup xmlns:xlink="http://www.w3.org/1999/xlink">av-3J</sup>
###xml 576 1181 576 1181 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="39"><bold>a</bold> Mouse loss-of function mutations in Pcdh15 investigated in this study. The <italic>solid rectangle</italic> indicates protein truncation due to premature stop mutations in the mutant mouse. <italic>N-ter</italic> N-terminus of the amino acid sequence, <italic>C1</italic> cadherin domain 1, <italic>C2</italic> cadherin domain 2, etc.; <italic>C-ter</italic> C-terminus of the amino acid sequence. <bold>b</bold> Levels of TGs and total cholesterol in the Pcdh15 mouse mutant in the loss-of-function allele Pcdh15<sup>av-3J</sup>, when compared to sibling controls. Groups of mice were as follows: 9 mutant and 11 control mice (C57BL/6J genetic background). TG and total cholesterol levels are expressed in mg/dl</p>
###xml 576 1181 576 1181 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="39"><bold>a</bold> Mouse loss-of function mutations in Pcdh15 investigated in this study. The <italic>solid rectangle</italic> indicates protein truncation due to premature stop mutations in the mutant mouse. <italic>N-ter</italic> N-terminus of the amino acid sequence, <italic>C1</italic> cadherin domain 1, <italic>C2</italic> cadherin domain 2, etc.; <italic>C-ter</italic> C-terminus of the amino acid sequence. <bold>b</bold> Levels of TGs and total cholesterol in the Pcdh15 mouse mutant in the loss-of-function allele Pcdh15<sup>av-3J</sup>, when compared to sibling controls. Groups of mice were as follows: 9 mutant and 11 control mice (C57BL/6J genetic background). TG and total cholesterol levels are expressed in mg/dl</p></caption>
###xml 1181 1181 1181 1181 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="439_2009_749_Fig3_HTML" id="MO3"/>
###xml 570 1181 570 1181 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig3"><label>Fig.&#160;3</label><caption><p textid="39"><bold>a</bold> Mouse loss-of function mutations in Pcdh15 investigated in this study. The <italic>solid rectangle</italic> indicates protein truncation due to premature stop mutations in the mutant mouse. <italic>N-ter</italic> N-terminus of the amino acid sequence, <italic>C1</italic> cadherin domain 1, <italic>C2</italic> cadherin domain 2, etc.; <italic>C-ter</italic> C-terminus of the amino acid sequence. <bold>b</bold> Levels of TGs and total cholesterol in the Pcdh15 mouse mutant in the loss-of-function allele Pcdh15<sup>av-3J</sup>, when compared to sibling controls. Groups of mice were as follows: 9 mutant and 11 control mice (C57BL/6J genetic background). TG and total cholesterol levels are expressed in mg/dl</p></caption><graphic position="anchor" xlink:href="439_2009_749_Fig3_HTML" id="MO3"/></fig>
###xml 72 77 <span type="species:ncbi:10090">mouse</span>
###xml 123 128 <span type="species:ncbi:10090">mouse</span>
###xml 578 583 <span type="species:ncbi:10090">Mouse</span>
###xml 744 749 <span type="species:ncbi:10090">mouse</span>
###xml 943 948 <span type="species:ncbi:10090">mouse</span>
###xml 1045 1049 <span type="species:ncbi:10090">mice</span>
###xml 1091 1095 <span type="species:ncbi:10090">mice</span>
To investigate possible alterations in the lipid profiles of the Pcdh15 mouse mutants, we measured the lipid levels of two mouse mutants homozygous for different loss of function mutation in Pcdh15 (Pcdh15av-Tg and Pcdh15av-3J) (Fig. 3a). We observed a significant decrease in plasma TG and TC concentrations between the Pcdh15av-3J homozygotes and age-match wild type siblings (P = 0.013 and P = 0.044, respectively) (Fig. 3b). No statistically significant differences were observed between the Pcdh15av-Tg homozygotes and controls for any lipid trait (data not shown).Fig. 3a Mouse loss-of function mutations in Pcdh15 investigated in this study. The solid rectangle indicates protein truncation due to premature stop mutations in the mutant mouse. N-ter N-terminus of the amino acid sequence, C1 cadherin domain 1, C2 cadherin domain 2, etc.; C-ter C-terminus of the amino acid sequence. b Levels of TGs and total cholesterol in the Pcdh15 mouse mutant in the loss-of-function allele Pcdh15av-3J, when compared to sibling controls. Groups of mice were as follows: 9 mutant and 11 control mice (C57BL/6J genetic background). TG and total cholesterol levels are expressed in mg/dl
###end p 38
###begin p 39
###xml 0 1 0 1 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 77 92 77 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">solid rectangle</italic>
###xml 175 180 175 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N-ter</italic>
###xml 220 222 220 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C1</italic>
###xml 242 244 242 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C2</italic>
###xml 270 275 270 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C-ter</italic>
###xml 315 316 315 316 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 417 422 417 422 <sup xmlns:xlink="http://www.w3.org/1999/xlink">av-3J</sup>
###xml 2 7 <span type="species:ncbi:10090">Mouse</span>
###xml 168 173 <span type="species:ncbi:10090">mouse</span>
###xml 367 372 <span type="species:ncbi:10090">mouse</span>
###xml 469 473 <span type="species:ncbi:10090">mice</span>
###xml 515 519 <span type="species:ncbi:10090">mice</span>
a Mouse loss-of function mutations in Pcdh15 investigated in this study. The solid rectangle indicates protein truncation due to premature stop mutations in the mutant mouse. N-ter N-terminus of the amino acid sequence, C1 cadherin domain 1, C2 cadherin domain 2, etc.; C-ter C-terminus of the amino acid sequence. b Levels of TGs and total cholesterol in the Pcdh15 mouse mutant in the loss-of-function allele Pcdh15av-3J, when compared to sibling controls. Groups of mice were as follows: 9 mutant and 11 control mice (C57BL/6J genetic background). TG and total cholesterol levels are expressed in mg/dl
###end p 39
###begin title 40
Discussion
###end title 40
###begin p 41
###xml 79 85 79 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCDH15</italic>
###xml 295 299 295 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR21">2004</xref>
###xml 611 615 611 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR28">2002</xref>
Results from our study suggest that the common allele of SNP rs10825269 within PCDH15 is associated with TG, apo-B and TC levels in FCHL. This SNP resides in the same exon as the microsatellite D10S546 that was previously associated with high TGs in the Finnish families with FCHL (Lilja et al. 2004). The functional role of the amino acid substitution G380S in the lipid metabolism is unknown. This amino acid substitution is located in the extracellular domain and resides in a highly conserved residue. Although the amino acid change was predicted to be benign using the Polyphen software (Ramensky and Bork 2002), nonsynonymous SNPs in the coding region of a gene could affect the structure and function of the protein. It also remains possible that SNP rs10825269 is in linkage disequilibrium with another functional DNA variant at this locus.
###end p 41
###begin p 42
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCDH15</italic>
###xml 98 104 98 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCDH15</italic>
###xml 206 212 206 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCDH15</italic>
###xml 275 279 275 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR3">2003</xref>
###xml 358 362 358 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2001</xref>
###xml 381 386 381 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">2001a</xref>
###xml 398 404 398 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCDH15</italic>
###xml 609 613 609 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">1998</xref>
###xml 816 820 816 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR30">1964</xref>
###xml 837 841 837 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR29">1965</xref>
###xml 856 860 856 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">2006</xref>
###xml 875 879 875 879 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">2007</xref>
###xml 1190 1196 1190 1196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCDH15</italic>
###xml 1310 1315 1310 1315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">2001a</xref>
###xml 1341 1345 1341 1345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR31">2006</xref>
###xml 1389 1395 1389 1395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCDH15</italic>
###xml 1483 1488 1483 1488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">2001b</xref>
###xml 1514 1518 1514 1518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR31">2006</xref>
###xml 1559 1565 1559 1565 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCDH15</italic>
###xml 512 520 <span type="species:ncbi:9606">patients</span>
###xml 1399 1404 <span type="species:ncbi:9606">human</span>
###xml 1460 1464 <span type="species:ncbi:10090">mice</span>
###xml 1582 1587 <span type="species:ncbi:9606">human</span>
PCDH15 is a member of the cadherin superfamily of calcium-dependent cell-cell adhesion molecules. PCDH15 plays an essential role in the maintenance of normal retinal and cochlear function, and mutations in PCDH15 have been associated with nonsyndromic (DFNB23) (Ahmed et al. 2003) and syndromic hearing loss (the Usher syndrome type 1F, USH1F) (Ahmed et al. 2001; Alagramam et al. 2001a). Although PCDH15 has not been directly related with lipid abnormalities, previous biochemical analysis suggested that USH1F patients have decreased levels of long-chain polyunsaturated fatty acids in plasma (Maude et al. 1998). In addition, previous epidemiological studies have linked hearing loss to lipid abnormalities, showing that hyperlipidemia and atherosclerosis can induce alteration in cochlear function (Rosen et al. 1964; Rosen and Olin 1965; Evans et al. 2006; Chang et al. 2007). The biological role of protocadherins in lipid abnormalities is unclear. The large size and diversity of members of the protocadherin family suggest the participation of these proteins in a wide variety of biological processes. Previous studies of the Usher syndrome and visual abnormalities have shown that PCDH15 is expressed in several tissues including retina, brain, cerebellum, kidney, cochlea and liver (Alagramam et al. 2001a; Rouget-Quermalet et al. 2006). In this study, the expression pattern of PCDH15 in human was consistent with the pattern previously observed in mice (Alagramam et al. 2001b; Rouget-Quermalet et al. 2006). Importantly, we also demonstrate that PCDH15 is expressed in human pancreas. Further investigation is necessary to confirm the role of PCDH15 in lipid abnormalities.
###end p 42
###begin p 43
###xml 303 308 303 308 <sup xmlns:xlink="http://www.w3.org/1999/xlink">av-3J</sup>
###xml 404 409 404 409 <sup xmlns:xlink="http://www.w3.org/1999/xlink">av-Tg</sup>
###xml 747 751 747 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">2006</xref>
###xml 922 926 922 926 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR23">2001</xref>
###xml 108 113 <span type="species:ncbi:10090">mouse</span>
###xml 273 278 <span type="species:ncbi:10090">mouse</span>
To the best of our knowledge, this is the first time that lipid traits have been investigated in the Pcdh15 mouse mutant. Although additional studies are necessary to confirm our findings, these observations suggest a possible alteration in the lipid profile of the Pcdh15 mouse mutant due to the Pcdh15av-3J loss-of-function mutation. No statistically significant differences were observed in the Pcdh15av-Tg loss-of-function mutation. The observed results suggest differences in the genetic background between the FVB/N and C57BL/6J strains. This suggestion is indirectly supported by a previous study demonstrating that the FVB/N strain is susceptible to diet induce-atherosclerosis whereas the C57BL/6J strain is resistant (Hoover-Plow et al. 2006). A given phenotype could be obvious in one inbred genetic background but it could be suppressed in another genetic background (potential genetic modifier effect; Nadeau 2001).
###end p 43
###begin p 44
###xml 457 461 457 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR26">2004</xref>
###xml 486 490 486 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">2005</xref>
###xml 492 496 492 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR16">2008</xref>
###xml 522 526 522 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR33">2006</xref>
###xml 539 543 539 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">2008</xref>
###xml 561 565 561 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR27">2009</xref>
Genome-wide association analyses in unrelated individuals have identified several loci associated with lipid abnormalities. However, the variants identified so far explain a small fraction of the disease risk, suggesting that many genes implicated in the lipid metabolism still remain undiscovered. We have previously identified several genes associated with FCHL using family-based studies and replicated our results in different cohorts (Pajukanta et al. 2004; Huertas-Vazquez et al. 2005, 2008; Weissglas-Volkov et al. 2006; Lee et al. 2008; Plaisier et al. 2009). Family-based studies are more robust to population stratification and families ascertained for the disease of interest provide a powerful tool for association studies.
###end p 44
###begin p 45
###xml 61 67 61 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCDH15</italic>
###xml 217 223 217 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCDH15</italic>
###xml 272 278 272 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCDH15</italic>
In conclusion, we have identified a nonsynonymous variant in PCDH15 associated with TG, apo-B and TC levels in multigenerational Caucasian FCHL families. Replication in additional FCHL study samples and sequencing of PCDH15 are warranted to further explore the effects of PCDH15 in FCHL.
###end p 45
###begin p 46
###xml 13 21 <span type="species:ncbi:9606">patients</span>
###xml 375 380 <span type="species:ncbi:9606">Human</span>
We thank the patients and family members for their participation in this study. We thank L. Peltonen, I. Nuotio and J. S. A. Viikari for sample collection. We thank Janet Sinsheimer and Daphna Weissglas-Volkov for their advice in the statistical analysis; as well as E. Nikkola and M. Lupsakko for laboratory technical assistance. C. L. Plaisier is supported by the National Human Genome Research Institute grant T32 HG02536. M.-R. Taskinen is supported by a grant from Finnish Heart Foundation. This research was supported by the National Institutes of Health grant HL-28481 and the American Heart Association grant 0725232Y. T. W. A. de Bruin has been employed by GlaxoSmithKline. This work was not supported in full or part by GlaxoSmithKline. We would like to thank Janis Paulsey in the laboratory of K. Alagramam for technical assistance with animal work.
###end p 46
###begin p 47
###xml 0 11 0 11 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Open Access</bold>
Open Access This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
###end p 47
###begin title 48
References
###end title 48
###begin article-title 49
A general test of association for quantitative traits in nuclear families
###end article-title 49
###begin article-title 50
###xml 36 42 36 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCDH15</italic>
Mutations of the protocadherin gene PCDH15 cause Usher syndrome type 1F
###end article-title 50
###begin article-title 51
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCDH15</italic>
PCDH15 is expressed in the neurosensory epithelium of the eye and ear and mutant alleles are responsible for both USH1F and DFNB23
###end article-title 51
###begin article-title 52
###xml 37 43 37 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCDH15</italic>
Mutations in the novel protocadherin PCDH15 cause Usher syndrome type 1F
###end article-title 52
###begin article-title 53
###xml 4 9 <span type="species:ncbi:10090">mouse</span>
The mouse Ames waltzer hearing-loss mutant is caused by mutation of Pcdh15, a novel protocadherin gene
###end article-title 53
###begin article-title 54
Locus for elevated apolipoprotein B levels on chromosome 1p31 in families with familial combined hyperlipidemia
###end article-title 54
###begin article-title 55
A genome scan for familial combined hyperlipidemia reveals evidence of linkage with a locus on chromosome 11
###end article-title 55
###begin article-title 56
Small, dense LDL and elevated apolipoprotein B are the common characteristics for the three major lipid phenotypes of familial combined hyperlipidemia
###end article-title 56
###begin article-title 57
Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia
###end article-title 57
###begin article-title 58
###xml 43 58 <span type="species:ncbi:10090">transgenic mice</span>
###xml 74 79 <span type="species:ncbi:10090">mouse</span>
Mechanisms mediating insulin resistance in transgenic mice overexpressing mouse apolipoprotein A-II
###end article-title 58
###begin article-title 59
Hyperlipidemia in noise-induced hearing loss
###end article-title 59
###begin article-title 60
Dyslipidemia and auditory function
###end article-title 60
###begin article-title 61
Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia
###end article-title 61
###begin article-title 62
Genetic background determines response to hemostasis and thrombosis
###end article-title 62
###begin article-title 63
TCF7L2 is associated with high serum triacylglycerol and differentially expressed in adipose tissue in families with familial combined hyperlipidaemia
###end article-title 63
###begin article-title 64
Extensions to pedigree analysis. IV. Covariance components models for multivariate traits
###end article-title 64
###begin article-title 65
Extensions to pedigree analysis. III. Variance components by the scoring method
###end article-title 65
###begin article-title 66
MENDEL version 4.0: a complete package for the exact genetic analysis of discrete traits in pedigree and population data sets
###end article-title 66
###begin article-title 67
WW-domain-containing oxidoreductase is associated with low plasma HDL-C levels
###end article-title 67
###begin article-title 68
Locus for quantitative HDL-cholesterol on chromosome 10q in Finnish families with dyslipidemia
###end article-title 68
###begin article-title 69
Polyunsaturated fatty acids are lower in blood lipids of Usher's type I but not Usher's type II
###end article-title 69
###begin article-title 70
###xml 18 22 <span type="species:ncbi:10090">mice</span>
###xml 27 33 <span type="species:ncbi:9606">humans</span>
Modifier genes in mice and humans
###end article-title 70
###begin article-title 71
PedCheck: a program for identification of genotype incompatibilities in linkage analysis
###end article-title 71
###begin article-title 72
Genomewide scan for familial combined hyperlipidemia genes in Finnish families, suggesting multiple susceptibility loci influencing triglyceride, cholesterol and apolipoprotein B levels
###end article-title 72
###begin article-title 73
Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1)
###end article-title 73
###begin article-title 74
Galanin preproprotein is associated with elevated plasma triglycerides
###end article-title 74
###begin article-title 75
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human non-synonymous SNPs: server and survey
###end article-title 75
###begin article-title 76
Hearing loss and coronary heart disease
###end article-title 76
###begin article-title 77
Relation of hearing loss to cardiovascular disease
###end article-title 77
###begin article-title 78
###xml 18 24 18 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCDH15</italic>
Protocadherin 15 (PCDH15): a new secreted isoform and a potential marker for NK/T cell lymphomas
###end article-title 78
###begin article-title 79
Genome scans provide evidence for low-HDL-C loci on chromosomes 8q23, 16q24.1-24.2, and 20q13.11 in Finnish families
###end article-title 79
###begin article-title 80
Common hepatic nuclear factor-4alpha variants are associated with high serum lipid levels and the metabolic syndrome
###end article-title 80

